Activities of mixed NOP and μ‐opioid receptor ligands
Barbara Spagnolo(University of Salento), Nurulain T. Zaveri(Astraea Therapeutics (United States)), Stephen M. Husbands(University of Bath), Lawrence Toll(Florida Atlantic University), Girolamo Calò(University of Padua), Faming Jiang(SRI International), Ilona P. Berzetei‐Gurske(SRI International), Taline V. Khroyan(SRI International), Willma E. Polgar(SRI International), John W. Lewis(University of Bath), Christopher M. Olsen(Medical College of Wisconsin)
Cited by 62
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Pharmacology of nociceptin and its receptor: a novel therapeutic target
|British Journal of Pharmacology|2000|432
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems
|Pharmacological Reviews|2016|290